cbdMD (YCBD) Common Equity (2016 - 2025)

cbdMD has disclosed Common Equity across 10 years of filings, most recently posting $9.0 million for Q4 2025.

• Common Equity for Q4 2025 came in at $9.0 million, up 405.61% year-over-year; the trailing twelve-month figure through Dec 2025 was $9.0 million (up 405.61% YoY), and the FY2025 annual result was $7.2 million, up 268.04% from the prior year.
• Common Equity came in at $9.0 million for Q4 2025 at cbdMD, up from $7.2 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $103.1 million in Q3 2021 to a low of $665798.0 in Q1 2025.
• The 5-year median for Common Equity is $17.4 million (2023), against an average of $32.4 million.
• Across the five-year window, Common Equity slumped 88.23% in 2024 and surged 405.61% in 2025, its largest moves.
• cbdMD's Common Equity stood at $84.4 million in 2021, then plunged by 68.49% to $26.6 million in 2022, then sank by 73.54% to $7.0 million in 2023, then sank by 74.68% to $1.8 million in 2024, then soared by 405.61% to $9.0 million in 2025.
• The last three Common Equity figures came in at $9.0 million (Q4 2025), $7.2 million (Q3 2025), and $6.1 million (Q2 2025), per Business Quant data.